Antimicrobial peptides as potential alternatives to antibiotics in food animal industry

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  Wang, Shuai ^a   Zeng, Xiangfang ^a   Yang, Qing ^a   Qiao, Shiyan ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antibiotic resistance; Antimicrobial peptides; Applications; Poultry; Swine

Indexed keywords

BETA DEFENSIN 3; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN; DEFENSIN; DENDRIMER; DERMASEPTIN; FOOD ADDITIVE; LACTOFERRIN; LINCOMYCIN; MAGAININ DERIVATIVE; PLECTASIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; BACILLUS MEGATERIUM; BROILER; DRUG ACTIVITY; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; ESCHERICHIA COLI; FOOD INDUSTRY; HERPES SIMPLEX VIRUS 1; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFLAMMATION; INTESTINE FLORA; KERATINOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS LUTEUS; NONHUMAN; NUCLEIC ACID SYNTHESIS; NUTRITIONAL VALUE; PIG; POULTRY; PSEUDOMONAS AERUGINOSA; REVIEW; VIRUS INFECTION; XENOPUS LAEVIS; ANIMAL; ANIMAL FOOD; CHEMISTRY; CHICKEN; DRUG EFFECTS; MICROBIOLOGY;

ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHICKENS; GASTROINTESTINAL MICROBIOME; SWINE;

EID: 84965018489     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050603     Document Type: Review

References (69)

1. Cromwell, G. L. Why and how antibiotics are used in swine production. Anim. Biotechnol. 2002, 13, 7-27. [CrossRef] [PubMed]
2. Van Boeckel, T. P.; Brower, C.; Gilbert, M.; Grenfell, B. T.; Levin, S. A.; Robinson, T. P.; Teillant, A.; Laxminarayan, R. Global trends in antimicrobial use in food animals. Proc. Natl. Acad. Sci. USA 2015, 112, 5649-5654. [CrossRef] [PubMed]
3. O'Neill, J. Antimicrobial peptides: Tackling of a crisis for the health and wealth of nations. Available online: http: //amr-review. org/sites/fefault/files/AMR%20Review%20paper%20-%20Tackling%20a%20crisis% 20for%20the%20health%20and%20wealth%20of%20nations_1. pdf (accessed on December 2014).
4. Alanis, A. J. Resistance to antibiotics: Are we in the post-antibiotic era? Arch. Med. Res. 2005, 36, 697-705. [CrossRef] [PubMed]
5. Lata, S.; Sharma, B. K.; Raghava, G. P. Analysis and prediction of antibacterial peptides. BMC Bioinform. 2007, 8, 263. [CrossRef] [PubMed]
6. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395. [CrossRef] [PubMed]
7. Bradshaw, J. P. Cationic antimicrobial peptides-Issues for potential clinical use. Biodrugs 2003, 17, 233-240. [CrossRef] [PubMed]
8. Lai, Y.; Gallo, R. L. AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30, 131-141. [CrossRef] [PubMed]
9. Peschel, A.; Sahl, H. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4, 529-536. [CrossRef] [PubMed]
10. Wang, S.; Thacker, P. A.; Watford, M.; Qiao, S. Functions of Antimicrobial Peptides in Gut Homeostasis. Curr. Protein Pept. Sci. 2015, 16, 582-591. [CrossRef] [PubMed]
11. Hancock, R. E. Cationic peptides: Effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1, 156-164. [CrossRef]
12. Zhang, L. J.; Parente, J.; Harris, S. A.; Woods, D. E.; Hancock, R.; Fallal, T. J. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 2005, 49, 2921-2927. [CrossRef] [PubMed]
13. Powers, J. P.; Hancock, R. E. The relationship between peptide structure and antibacterial activity. Peptides 2003, 24, 1681-1691. [CrossRef] [PubMed]
14. Brogden, K. A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250. [CrossRef] [PubMed]
15. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta-Biomembr. 1999, 1462, 55-70. [CrossRef]
16. Yang, L.; Harroun, T. A.; Weiss, T. M.; Ding, L.; Huang, H. W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 2001, 81, 1475-1485. [CrossRef]
17. Hoffmann, J. A. Innate immunity of insects. Curr. Opin. Immunol. 1995, 7, 4-10. [CrossRef]
18. Andreu, D.; Merrifield, R. B.; Steiner, H.; Boman, H. G. N-terminal analogues of cecropin A: Synthesis, antibacterial activity, and conformational properties. Biochemistry 1985, 24, 1683-1688. [CrossRef] [PubMed]
19. Silvestro, L.; Weiser, J. N.; Axelsen, P. H. Antibacterial and antimembrane activities of cecropin A in Escherichia coli. Antimicrob. Agents Chemother. 2000, 44, 602-607. [CrossRef] [PubMed]
20. Hoffmann, J. A.; Hetru, C. Insect defensins: Inducible antibacterial peptides. Immunol. Today 1992, 13, 411-415. [CrossRef]
21. Simmaco, M.; Mignogna, G.; Barra, D. Antimicrobial peptides from amphibian skin: What do they tell us? Biopolymers 1998, 47, 435-450. [CrossRef]
22. Wang, Y.; Zhang, Y.; Lee, W. H.; Yang, X.; Zhang, Y. Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities. Chem. Biol. Drug Des. 2016, 87, 419-424. [CrossRef] [PubMed]
23. Lin, Y.; Hu, N.; Lyu, P.; Ma, J.; Wang, L.; Zhou, M.; Guo, S.; Chen, T.; Shaw, C. Hylaranins: Prototypes of a new class of amphibian antimicrobial peptide from the skin secretion of the oriental broad-folded frog, Hylarana latouchii. Amino Acids 2014, 46, 901-909. [CrossRef] [PubMed]
24. Verma, C.; Seebah, S.; Low, S. M.; Zhou, L.; Liu, S. P.; Li, J.; Beuerman, R. W. Defensins: Antimicrobial peptides for therapeutic development. Biotechnol. J. 2007, 2, 1353-1359. [CrossRef] [PubMed]
25. Harder, J.; Bartels, J.; Christophers, E.; Schroder, J. M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276, 5707-5713. [CrossRef] [PubMed]
26. Bals, R.; Wang, X.; Zasloff, M.; Wilson, J. M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 1998, 95, 9541-9546. [CrossRef] [PubMed]
27. Dean, S. N.; Bishop, B. M.; van Hoek, M. L. Susceptibility of pseudomonas aeruginosa biofilm to α-helical peptides: D-enantiomer of LL-37. Front. Microbiol. 2011, 2, 128. [CrossRef] [PubMed]
28. Turner, J.; Cho, Y.; Dinh, N. N.; Waring, A. J.; Lehrer, R. I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 1998, 42, 2206-2214. [PubMed]
29. Li, Y.; Xiang, Q.; Zhang, Q.; Huang, Y.; Su, Z. Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application. Peptides 2012, 37, 207-215. [CrossRef] [PubMed]
30. De Lucca, A. J.; Walsh, T. J. Antifungal peptides: Novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother. 1999, 43, 1-11. [PubMed]
31. Benincasa, M.; Scocchi, M.; Pacor, S.; Tossi, A.; Nobili, D.; Basaglia, G.; Busetti, M.; Gennaro, R. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 2006, 58, 950-959. [CrossRef] [PubMed]
32. Vylkova, S.; Nayyar, N.; Li, W.; Edgerton, M. Human β-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 2007, 51, 154-161. [CrossRef] [PubMed]
33. Tsai, P. W.; Yang, C. Y.; Chang, H. T.; Lan, C. Y. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 2011, 6, e17755. [CrossRef] [PubMed]
34. Jenssen, H.; Hamill, P.; Hancock, R. E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491-511. [CrossRef] [PubMed]
35. Torres, N. I.; Noll, K. S.; Xu, S.; Li, J.; Huang, Q.; Sinko, P. J.; Wachsman, M. B.; Chikindas, M. L. Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob. Proteins 2013, 5, 26-35. [CrossRef] [PubMed]
36. Barlow, P. G.; Svoboda, P.; Mackellar, A.; Nash, A. A.; York, I. A.; Pohl, J.; Davidson, D. J.; Donis, R. O. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE 2011, 6, e25333. [CrossRef] [PubMed]
37. Lorin, C.; Saidi, H.; Belaid, A.; Zairi, A.; Baleux, F.; Hocini, H.; Bélec, L.; Hani, K.; Tangy, F. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 2005, 334, 264-275. [CrossRef] [PubMed]
38. Tripathi, S.; Tecle, T.; Verma, A.; Crouch, E.; White, M.; Hartshorn, K. L. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J. Gen. Virol. 2013, 94, 40-49. [CrossRef] [PubMed]
39. Feng, Z.; Dubyak, G. R.; Lederman, M. M.; Weinberg, A. Cutting edge: Human β defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol. 2006, 177, 782-786. [CrossRef] [PubMed]
40. Gallo, S. A.; Wang, W.; Rawat, S. S.; Jung, G.; Waring, A. J.; Cole, A. M.; Lu, H.; Yan, X.; Daly, N. L.; Craik, D. J.; et al. θ-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J. Biol. Chem. 2006, 281, 18787-18792. [CrossRef] [PubMed]
41. Pires, J.; Siriwardena, T. N.; Stach, M.; Tinguely, R.; Kasraian, S.; Luzzaro, F.; Leib, S. L.; Darbre, T.; Reymond, J. L.; Endimiani, A. In vitro activity of the novel antimicrobial peptide dendrimer G3KL against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2015, 59, 7915-7918. [CrossRef] [PubMed]
42. Rajamuthiah, R.; Jayamani, E.; Conery, A. L.; Fuchs, B. B.; Kim, W.; Johnston, T.; Vilcinskas, A.; Ausubel, F. M.; Mylonakis, E. A Defensin from the model beetle tribolium castaneum acts synergistically with telavancin and daptomycin against multidrug resistant Staphylococcus aureus. PLoS ONE 2015, 10, e128576. [CrossRef] [PubMed]
43. Feng, X.; Sambanthamoorthy, K.; Palys, T.; Paranavitana, C. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides 2013, 49, 131-137. [CrossRef] [PubMed]
44. Marr, A. K.; Gooderham, W. J.; Hancock, R. E. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr. Opin. Pharmacol. 2006, 6, 468-472. [CrossRef] [PubMed]
45. Hancock, R. E.; Sahl, H. G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24, 1551-1557. [CrossRef] [PubMed]
46. Zhu, S.; Gao, B. A fossil antibacterial peptide gives clues to structural diversity of cathelicidin-derived host defense peptides. FASEB J. 2009, 23, 13-20. [CrossRef] [PubMed]
47. Pag, U.; Sahl, H. G. Multiple activities in lantibiotics-models for the design of novel antibiotics? Curr. Pharm. Des. 2002, 8, 815-833. [CrossRef] [PubMed]
48. Mansour, S. C.; Pena, O. M.; Hancock, R. E. Host defense peptides: Front-line immunomodulators. Trends Immunol. 2014, 35, 443-450. [CrossRef] [PubMed]
49. Ren, Z. H.; Yuan, W.; Deng, H. D.; Deng, J. L.; Dan, Q. X.; Jin, H. T.; Tian, C. L.; Peng, X.; Liang, Z.; Gao, S.; et al. Effects of antibacterial peptide on cellular immunity in weaned piglets. J. Anim. Sci. 2015, 93, 127-134. [CrossRef] [PubMed]
50. Shan, T.; Wang, Y.; Wang, Y.; Liu, J.; Xu, Z. Effect of dietary lactoferrin on the immune functions and serum iron level of weanling piglets. J. Anim. Sci. 2007, 85, 2140-2146. [CrossRef] [PubMed]
51. Liu, T.; She, R.; Wang, K.; Bao, H.; Zhang, Y.; Luo, D.; Hu, Y.; Ding, Y.; Wang, D.; Peng, K. Effects of rabbit sacculus rotundus antimicrobial peptides on the intestinal mucosal immunity in chickens. Poult. Sci. 2008, 87, 250-254. [CrossRef] [PubMed]
52. Bao, H.; She, R.; Liu, T.; Zhang, Y.; Peng, K. S.; Luo, D.; Yue, Z.; Ding, Y.; Hu, Y.; Liu, W.; et al. Effects of pig antibacterial peptides on growth performance and intestine mucosal immune of broiler chickens. Poult. Sci. 2009, 88, 291-297. [CrossRef] [PubMed]
53. Wang, D.; Ma, W.; She, R.; Sun, Q.; Liu, Y.; Hu, Y.; Liu, L.; Yang, Y.; Peng, K. Effects of swine gut antimicrobial peptides on the intestinal mucosal immunity in specific-pathogen-free chickens. Poult. Sci. 2009, 88, 967-974. [CrossRef] [PubMed]
54. Thacker, P. A. Alternatives to antibiotics as growth promoters for use in swine production: A review. J. Anim. Sci. Biotechnol. 2013, 4, 35. [CrossRef] [PubMed]
55. Xiao, H.; Shao, F.; Wu, M.; Ren, W.; Xiong, X.; Tan, B.; Yin, Y. The application of antimicrobial peptides as growth and health promoters for swine. J. Anim. Sci. Biotechnol. 2015, 6, 19. [CrossRef] [PubMed]
56. Wang, Y.; Shan, T.; Xu, Z.; Liu, J.; Feng, J. Effect of lactoferrin on the growth performance, intestinal morphology, and expression of PR-39 and protegrin-1 genes in weaned piglets. J. Anim. Sci. 2006, 84, 2636-2641. [CrossRef] [PubMed]
57. Tang, Z.; Yin, Y.; Zhang, Y.; Huang, R.; Sun, Z.; Li, T.; Chu, W.; Kong, X.; Li, L.; Geng, M.; et al. Effects of dietary supplementation with an expressed fusion peptide bovine lactoferricin-lactoferrampin on performance, immune function and intestinal mucosal morphology in piglets weaned at age 21 d. Br. J. Nutr. 2009, 101, 998-1005. [CrossRef] [PubMed]
58. Yoon, J. H.; Ingale, S. L.; Kim, J. S.; Kim, K. H.; Lee, S. H.; Park, Y. K.; Kwon, I. K.; Chae, B. J. Effects of dietary supplementation of antimicrobial peptide-A3 on growth performance, nutrient digestibility, intestinal and fecal microflora and intestinal morphology in weanling pigs. Anim. Feed Sci. Technol. 2012, 177, 98-107. [CrossRef]
59. Yoon, J. H.; Ingale, S. L.; Kim, J. S.; Kim, K. H.; Lohakare, J.; Park, Y. K.; Park, J. C.; Kwon, I. K.; Chae, B. J. Effects of dietary supplementation with antimicrobial peptide-P5 on growth performance, apparent total tract digestibility, faecal and intestinal microflora and intestinal morphology of weanling pigs. J. Sci. Food Agric. 2013, 93, 587-592. [CrossRef] [PubMed]
60. Choi, S. C.; Ingale, S. L.; Kim, J. S.; Park, Y. K.; Kwon, I. K.; Chae, B. J. Effects of dietary supplementation with an antimicrobial peptide-P5 on growth performance, nutrient retention, excreta and intestinal microflora and intestinal morphology of broilers. Anim. Feed Sci. Technol. 2013, 85, 78-84. [CrossRef]
61. Choi, S. C.; Ingale, S. L.; Kim, J. S.; Park, Y. K.; Kwon, I. K.; Chae, B. J. An antimicrobial peptide-A3: Effects on growth performance, nutrient retention, intestinal and faecal microflora and intestinal morphology of broilers. Br. Poult. Sci. 2013, 54, 738-746. [CrossRef] [PubMed]
62. Wang, Y.; Shan, T.; Xu, Z.; Feng, J.; Wang, Z. Effects of the lactoferrin (LF) on the growth performance, intestinal microflora and morphology of weanling pigs. Anim. Feed Sci. Technol. 2007, 135, 263-272. [CrossRef]
63. Wang, Y. Z.; Xu, C. L.; An, Z. H.; Liu, J. X.; Feng, J. Effect of dietary bovine lactoferrin on performance and antioxidant status of piglets. Anim. Feed Sci. Technol. 2008, 140, 326-336. [CrossRef]
64. Xiao, H.; Wu, M. M.; Tan, B. E.; Yin, Y. L.; Li, T. J.; Xiao, D. F.; Li, L. Effects of composite antimicrobial peptides in weanling piglets challenged with deoxynivalenol: I. Growth performance, immune function, and antioxidation capacity. J. Anim. Sci. 2013, 91, 4772-4780. [CrossRef] [PubMed]
65. Wu, S.; Zhang, F.; Huang, Z.; Liu, H.; Xie, C.; Zhang, J.; Thacker, P. A.; Qiao, S. Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli. Peptides 2012, 35, 225-230. [CrossRef] [PubMed]
66. Wen, L. F.; He, J. G. Dose-response effects of an antimicrobial peptide, a cecropin hybrid, on growth performance, nutrient utilisation, bacterial counts in the digesta and intestinal morphology in broilers. Br. J. Nutr. 2012, 108, 1756-1763. [CrossRef] [PubMed]
67. Jin, Z.; Yang, Y. X.; Choi, J. Y.; Shinde, P. L.; Yoon, S. Y.; Hahn, T. W.; Lim, H. T.; Park, Y.; Hahm, K. S.; Joo, J. W.; et al. Potato (Solanum tuberosum L. cv. Gogu valley) protein as a novel antimicrobial agent in weanling pigs. J. Anim. Sci. 2008, 86, 1562-1572. [CrossRef] [PubMed]
68. Wang, S.; Zeng, X. F.; Wang, Q. W.; Zhu, J. L.; Peng, Q.; Hou, C. L.; Thacker, P.; Qiao, S. Y. The antimicrobial peptide sublancin ameliorates necrotic enteritis induced by Clostridium perfringens in broilers. J. Anim. Sci. 2015, 93, 4750-4760. [CrossRef] [PubMed]
69. Wan, J.; Li, Y.; Chen, D.; Yu, B.; Chen, G.; Zheng, P.; Mao, X.; Yu, J.; He, J. Recombinant plectasin elicits similar improvement in the performance and intestinal mucosa growth and activity in weaned pigs as an antibiotic. Anim. Feed Sci. Technol. 2016, 211, 216-226. [CrossRef]